More work is necessary to determine whether NMNAT2 levels or activity change over development in a manner that would differentially impact chemotherapy-induced changes in cell viability (measured in embryonic cultured cells) and chemotherapy-induced neuropathy (measured in adult mice). Here, NMNAT2 is linked to neuropathy.